Русский

Pharmaceutical Industry Information Portal

HomeTagsBristol Myers Squibb

All posts by tag

Bristol Myers Squibb

Логотип Бристоль-Майерс_Сквибб

Bristol Myers Squibb (BMS) — американская многонациональная фармацевтическая компания со штаб-квартирой в Нью-Йорке. BMS является одной из крупнейших в мире фармацевтических компаний и постоянно входит в список Fortune 500 крупнейших корпораций США. Bristol Myers Squibb производит рецептурные фармацевтические и биологические препараты в нескольких терапевтических областях, включая рак, ВИЧ / СПИД, сердечно-сосудистые заболевания, диабет, гепатит, ревматоидный артрит и психические расстройства.

Pharmaceutical Investing News

Bristol Myers must face $6.4 bln lawsuit over delayed cancer drug

Techno -
A U.S. judge on Friday refused to dismiss a $6.4 billion lawsuit accusing Bristol Myers Squibb Co of delaying its Breyanzi cancer drug to...
Pharmaceutical Investing News

Bristol Myers Squibb announces a $4.1 billion deal to acquire Turning Point Therapeutics

Techno -
Pharmaceutical giant Bristol Myers Squibb Company announced a $4.1 billion deal for Turning Point Therapeutics Inc  on Friday morning, the first sizable acquisition for...
Discovery and Development

BMS, Merck enter into $2.3 billion partnership with Amphista to discover and develop small molecule protein degraders

Techno -
Amphista Therapeutics, a global leader in the discovery and development of next generation targeted protein degradation (TPD) therapeutics, May 4th announced a strategic collaboration...
Newsletter

Bristol Myers Squibb sales grew in Q1 due to growth in line products

Techno -
Pharmaceutical company, drug maker Bristol Myers Squibb on Friday posted slightly higher-than-expected first-quarter earnings thanks to increased sales of its blood-thinning drug Eliquis and...
World Pharma News

Nektar Therapeutics and Bristol Myers Squibb stop clinical trials for key cancer drug

Techno -
Nektar Therapeutics and Bristol Myers Squibb announced that based on results from pre-planned analyses of two late-stage clinical studies of bempegaldesleukin (BEMPEG) in combination...
World Pharma News

FDA approves Bristol Myers’ Opdualag cancer immunotherapy

Techno -
Bristol Myers Squibb announced that OpdualagTM, a new, first-in-class, fixed-dose combination of nivolumab and relatlimab, administered as a single intravenous infusion, was approved by...
12Page 1 of 2
spot_img

Expert Articles

spot_img

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories